Complications and Challenges in the Management of Iraqi Patients with β-Thalassemia Major: A Single-Center Experience

Objectives: We sought to assess the complications and challenges facing the management of beta-thalassemia major (beta-TM) in Iraq. Methods: A total of 150 consecutive patients with beta-TM who were registered at a main thalassemia center in Northern Iraq were enrolled in the study. The patients had...

Full description

Saved in:
Bibliographic Details
Published in:Oman medical journal 2020-07, Vol.35 (4), p.1-7
Main Authors: Atroshi , Sulav D, Al-Allawi , Nasir A, Sadullah , Regir K
Format: Article
Language:English
Subjects:
ANTIBODIES
beta-thalassemia
Care
Diagnosis
Hemoglobin
HEPATITIS
Hepatitis C
hepatitis c antibodies
HEREDITARY DISEASES
Hypertension
Hypogonadism
IRAQ
Original
Patients
Prevention
Regulation
Synthesis
THALASSEMIA
Treatment
إلتهاب الكبد
الأجسام المضادة
الأمراض الوراثية
العراق
شحاب البحر المتوسط
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objectives: We sought to assess the complications and challenges facing the management of beta-thalassemia major (beta-TM) in Iraq. Methods: A total of 150 consecutive patients with beta-TM who were registered at a main thalassemia center in Northern Iraq were enrolled in the study. The patients had their records reviewed, were clinically evaluated, and investigated for various complications. Results: Our patient cohort had a median age of 13 years (range: 1-35 years) and a male to female ratio of 1:1.2. Their median serum ferritin was 2762 mug/L, all were on regular transfusions, 94.7% were on chelation therapy, and 38.0% were splenectomized. Pre-transfusion hemoglobin levels were >= 9.0 g/dL in 38.7% of the patients. Short stature was encountered in 33.9% of those aged
ISSN:1999-768X
2070-5204
DOI:10.5001/omj.2020.72